Join
Live feed
·
INSIDERFilingvia Quantisnow
Alto Neuroscience Inc. logo

Smith Nicholas Conrad bought $100,628 worth of shares (6,150 units at $16.36), increasing direct ownership by 30% to 26,866 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ANRO· Alto Neuroscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANRO (Alto Neuroscience Inc.) and more on Quantisnow.